Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1993 1
1994 1
1996 2
1997 1
1998 3
1999 3
2000 1
2001 3
2002 1
2003 4
2004 4
2005 2
2006 1
2007 2
2008 8
2009 11
2010 11
2011 13
2012 4
2013 14
2014 13
2015 11
2016 8
2017 16
2018 11
2019 12
2020 17
2021 13
2022 12
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Results by year

Filters applied: . Clear all
Page 1
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial.
Subbiah V, Kreitman RJ, Wainberg ZA, Gazzah A, Lassen U, Stein A, Wen PY, Dietrich S, de Jonge MJA, Blay JY, Italiano A, Yonemori K, Cho DC, de Vos FYFL, Moreau P, Fernandez EE, Schellens JHM, Zielinski CC, Redhu S, Boran A, Passos VQ, Ilankumaran P, Bang YJ. Subbiah V, et al. Among authors: passos vq. Nat Med. 2023 May;29(5):1103-1112. doi: 10.1038/s41591-023-02321-8. Epub 2023 Apr 14. Nat Med. 2023. PMID: 37059834 Free PMC article. Clinical Trial.
Group-based multi-trajectory modeling.
Nagin DS, Jones BL, Passos VL, Tremblay RE. Nagin DS, et al. Among authors: passos vl. Stat Methods Med Res. 2018 Jul;27(7):2015-2023. doi: 10.1177/0962280216673085. Epub 2016 Oct 17. Stat Methods Med Res. 2018. PMID: 29846144
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial.
Tan DSW, Felip E, de Castro G, Solomon BJ, Greystoke A, Cho BC, Cobo M, Kim TM, Ganguly S, Carcereny E, Paz-Ares L, Bennouna J, Garassino MC, Schenker M, Kim SW, Brase JC, Bury-Maynard D, Passos VQ, Deudon S, Dharan B, Song Y, Caparica R, Johnson BE. Tan DSW, et al. Among authors: passos vq. J Clin Oncol. 2024 Jan 10;42(2):192-204. doi: 10.1200/JCO.23.00980. Epub 2023 Dec 1. J Clin Oncol. 2024. PMID: 38039427 Clinical Trial.
Camellia sinensis in Dentistry: Technological Prospection and Scientific Evidence.
Valadas LAR, de Oliveira Filho RD, Rodrigues Neto EM, Bandeira MAM, Fonteles MMF, Passos VF, Fiallos ACM, Lotif MAL, de Sena NJC, Dantas TCFB, Lima Soares I, Lobo PLD, Squassi AF. Valadas LAR, et al. Among authors: passos vf. Evid Based Complement Alternat Med. 2021 Aug 30;2021:9966738. doi: 10.1155/2021/9966738. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34504542 Free PMC article. Review.
A Palliative Care Approach to Amyotrophic Lateral Sclerosis.
Gouveia C, Araújo L, Freitas S, Correia J, Passos V, Camacho G, Gomes L, Fragoeiro H, Camacho C, Chambino B. Gouveia C, et al. Among authors: passos v. Cureus. 2023 Dec 24;15(12):e51048. doi: 10.7759/cureus.51048. eCollection 2023 Dec. Cureus. 2023. PMID: 38264389 Free PMC article.
188 results